Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients

NeuroImmunoModulation

Volumn 14, Issue 1, 2007, Pages 8-15

  González, Alfonso ^b   Fazzino, Fili ^a   Castillo, Mirta ^b   Mata, Salvador ^b   Lima, Lucimey ^a,b  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b Hospital Vargas de Caracas   (Venezuela)

Author keywords

Lymphocyte proliferation; Major depression; Serotonin 5 HT1A receptor

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CONCANAVALIN A; DIATRIZOATE; FICOLL; IMIPRAMINE; MITOGENIC AGENT; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1 RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ANTAGONISM; FAMILY HISTORY; FEMALE; HAMILTON SCALE; HUMAN; INFORMED CONSENT; ISOLATION PROCEDURE; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MAJOR DEPRESSION; MALE; MENTAL DISEASE; OPTICAL DENSITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROFESSIONAL STANDARD; STIMULATION; CELL PROLIFERATION; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CELL PROLIFERATION; CONCANAVALIN A; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMIPRAMINE; LYMPHOCYTES; MALE; MIDDLE AGED; MITOGENS; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN AGENTS;

EID: 34548332488     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107283     Document Type: Article

References (55)

1. Müller N, Hofschuster E, Ackenheil M, Mempel W, Eckstein R: Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry 1993;77:713-730.
2. Rothermundt M, Arolt V, Fenker J, Gutbrodt H, Peters M, Kirchner H: Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci 2001;251:90-97.
3. Ravindran AV, Griffiths J, Merali Z, Anisman H: Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. J Affect Disord 1999;52:1-10.
4. Ravindran AV, Griffiths J, Merali Z, Anisman H: Variations of lymphocyte subsets associated with stress in depressive populations. Psychoneuroendocrinology 1996;21:659-662.
5. Ravindran AV, Griffiths J, Merali Z, Anisman H: Circulating lymphocyte subsets in major depression and dysthymia with typical or atypical features. Psychosom Med 1998;60:283-289.
6. Evans DK, Pedersen CA, Folds JD: Major depression and immunity: preliminary evidence of decreased natural killer cell populations. Neuropsychopharmacol Biol Psychiatry 1998;2:739-748.
7. Schleifer SJ, Keller, SE, Meyerson AT, Raskin M.J, Davis KL, Stein M: Lymphocyte function in major depressive disorder. Arch Gen Psychiatry 1984;41:484-486.
8. Maes M, Meltzer HY, Stevens W, Calabrese J, Cosyns P: Natural killer cell activity in major depression: relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology. Prog Neuropsychopharmacol Biol Psychiatry 1994;8:717-730.
9. Maes M, Lambrechts J, Suy E, Vandervorst C, Bosmans E: Absolute number and percentage of circulating natural killer, non-MHC-restricted T cytotoxic, and phagocytic cells in unipolar depression. Neuropsychobiology 1994;129:157-163.
10. Miller GE, Cohen S, Herbert TB: Pathways linking major depression and immunity in ambulatory female patients. Psychosom Med 1999;61:850-860.
11. Levy EM, Borrelli DJ, Mirin SM, Salt P, Knapp PH, Peirce C, Fox BH, Black PH: Biological measures and cellular immunological function in depressed psychiatric inpatients. Psychiatry Res 1991;36:157-167.
12. Anesi A, Franciotta D, Di Paolo E, Zardini E, Melzi d'Eril GV, Zerbi F: PHA-stimulated cellular immune function and T-lymphocyte subsets in major depressive disorders. Funct Neurol 1994;9:17-22.
13. Darko DF, Lucas AH, Gillin JC, Risch SC, Golshan S, Hamburger RN, Silverman MB, Janowsky DS: Cellular immunity and the hypothalamic-pituitary axis in major affective disorder: a preliminary study. Psychiatry Res 1988;25:1-9.
14. Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM: Interest of the use of pindolol in the treatment of depression: review. Encephale 2003;29:338-350.
15. Deakin JF: Depression and 5HT. Int Clin Psychopharmacol 1991;6(suppl 3):23-28.
16. Stahl SM: Neuroendocrine markers of serotonin responsivity in depression. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:655-659.
17. Stahl SM: Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 1998;51:215-235.
18. Dinnan TG, Majeed T, Lavelle E, Scott LV, Berti C, Behan P: Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology 1997;22:261-267.
19. Fuller RW: The involvement of serotonin in regulation of pituitary adrenocortical function. Front Neuroendocrinol 1992;13:250-270.
20. Guo AL, Petraglia F, Criscuolo M, Ficarra G, Salvestroni C, Nappi RE, Trentini GP, Genazzani AR: Adrenergic and serotoninergic receptors mediate the immunological activation of corticosterone secretion in male rats. Gynecol Endocrinol 1996;10:149-154.
21. Sher L, Oquendo MA, Galfalvy HC, Cooper TB, Mann JJ: The number of previous depressive episodes is positively associated with cortisol response to fenfluramine administration. Ann N Y Acad Sci 2004;1032:283-286.
22. Spurlock G, Buckland P, O'Donovan M, McGuffin P: Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 1994;33:433-440.
23. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C: PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999;46:1375-1387.
24. Fajardo O, Galeno J, Urbina M, Carreira I, Lima L: Serotonin, serotonin 5-HT(1A) receptors and dopamine in blood peripheral lymphocytes of major depression patients. Int Immunopharmacol 2003;3:1345-1352.
25. 1A -receptors and behaviour under chronic stress: selective counteraction by testosterone. Eur J Neurosci 1998;10:2685-2693.
26. 1A receptor mRNA expression in the limbic system of female rats. Brain Res Mol Brain Res 1998;55:169-172.
27. American Psychiatric Association: DSM-IV: Diagnostic and Statistical Manual for Mental Disorders, ed 3. Washington, American Psychiatric Association, 1994.
28. Hamilton MA: A rating scale of depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
29. 3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine. Int J Immunopharmacol 1999;21:631-646.
30. Mossman T: Rapid colorimetric assay for cellular growth and survival; application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
31. GraphPad Prism, version 4, 2003.
32. Mossner R, Lesch KP: Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 1998;12:249-271.
33. Masek K, Petrovicky P: Morphological and pharmacological evidence for the existence of brain regulatory circuits in the immune response. Int J Immunopharmacol 1997;19:507-510.
34. Mekori YA, Blickstein D, Baram D, Alter A, Radnay J, Rozensajn LA, Ravid M: Characterization of the interference of T cell activation by reserpine. Cell Immunol 1989;124:308-319.
35. Consentino M, Fietta AM, Ferrari M, Rasini E, Bombelli R, Carcano E, Saporiti F, Meloni F, Marino F, Lcchini S: Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood 2007;109:632-641.
36. Nahmod VE, Finkielman S, Fernández-Castelo S, Sterin-Princ A, Polack E Rubinstein E, Labeur M, Arzt ES: The central nervous system and neuroendocrine system in the regulation of the immune response. Medicina 1998;49:166-170.
37. Stefulj J, Jernej B, Cicin-Sain L, Rinner I, Schauenstein K: mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun 2000;14:219-224.
38. Ferriere F, Khan NA, Troutaud D, Deschaux P: Serotonin modulation of lymphocyte proliferation via 5-HT1A receptors in rainbow trout (Oncorhynchus mykiss). Dev Comp Immunol 1996;20:273-283.
39. 3H]-hydroxy-2-(di-n -propylamino)tetralin binding sites in blood lymphocytes of rats and the modulation by mitogens and immobilization. J Neuroimmunol 2003;138:8-16.
40. 1A receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytruptamine. J Immunol 1993;151:1175-1183.
41. Aune TM, Golden HW, McGrath KM: Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J Immunol 1994;153:489-498.
42. Mizrahi C, Stojanovic A, Urbina M, Carreira I, Lima L: Differential cAMP levels and serotonin effects in blood peripheral mononuclear cells and lymphocytes from major depression patients. Int Immunopharmacol 2004;4:1125-1133.
43. Leonard BE: The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry 2005;20(suppl 3):S302-S306.
44. Sher L: Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior. ScientificWorld Journal 2006;6:1398-1404.
45. Pace TW, Hu F, Miller AH: Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007;21:9-19.
46. 1A responsiveness in CA1 pyramidal neurons by in vivo activation of glucocorticoid receptors. J Neuroencodrinol 1996;8:433-438.
47. Pérez SA, Mahaira LG, Demirtzoglou FJ, Sotiropoulou PA, Ioannidis P, Iliopoulou EG, Gritzapis AD, Sotiriadou NN, Baxevanis CN, Papamichail M: A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival. Blood 2005;106:158-166.
48. Hennig J, Becker H, Netter P: 5-HT agonist-induced changes in peripheral immune cells in healthy volunteers: the impact of personality. Behav Brain Res 1996;73:359-363.
49. Idova GV, Cheido MA, Zhukova EN, Al'perina EL, Devoino LV: Effects of type 1A serotonin receptor agonist 8-OH-DPAT on immune response. Bull Exp Biol Med 2001;132:981-983.
50. 1A receptors mediate pindobind suppression of natural killer cell activity: modulation by catalase. Int Immunopharmacol 2001;1:247-253.
51. 1A and α-adrenergic receptors regulate proliferation of rat blood lymphocytes. Neuroimmunomodulation 2004;11:307-315.
52. 1A auto-receptor functioning in the rat dorsal raphe nucleus. Neuropharmacology 1995;43:1201-1210.
53. 1A receptors. Mol Neurosci 2004;15:1457-1459.
54. 1A receptor mRNA expression. J Neurosci 1993;13:914-923.
55. 1A receptor mRNA in rat dentate gyrus. Eur J Pharmacol 1994;266:255-261.